以色列魏茨曼科学研究所研制的一种药物有望开辟治疗Ｉ型糖尿病新途径。占总数约 1 5 %的糖尿病患者受Ｉ型糖尿病折磨 ,这种疾病使人寿命普遍缩短 1 5年。魏茨曼研究所和耶路撒冷市赫德萨医院的研究人员在 2 0 0 0年 1 1月 2 4日英国《柳叶刀》杂志上报道说取名Ｄｉａｐｅｐ2 7 A drug developed by the Weizmann Institute of Science in Israel is expected to open new avenues for the treatment of type 1 diabetes. About 1 in 5% of all diabetic patients are afflicted with type I diabetes, a disease that generally shortens life span by 15 years. Researchers from the Weizman Institute and the Hudson Hospital in Jerusalem reported in the British “Lancet” magazine on January 24, 2000 that Diapep 2 7